Amantadine use in influenza outbreaks in long-term care facilities

 

Table 1: Recommended amantadine hydrochloride dosage by age and renal status
Renal status Patient age, yr; dosage
1–9* 10–64 >= 65
No recognized renal disease 5mg/kg once daily, or, divided, twice daily; total daily dose not to exceed 150 mg 200 mg once daily or, divided, twice daily† 100 mg once daily‡
Recognized renal disease; creatinine
clearance,§ mL/min × 1.73m -2
>= 80 NA 100 mg twice daily 100 mg once daily
60–79 NA Alternating daily doses of 200 and 100 mg Alternating daily doses of 100 and 50 mg
40–59 NA 100 mg once daily 100 mg every 2 days
30–39 NA 200 mg twice weekly 100 mg twice weekly
20–29 NA 100 mg three times weekly 50 mg three times weekly
10–19 NA Alternating weekly doses of 200 and 100 mg Alternating weekly doses of 100 and 50 mg
*Use in children under 1 year of age has not been evaluated adequately.
†Reduction of dosage to 100 mg/d is recommended for people with a seizure disorder because they may be at risk for more frequent seizures when the dosage is 200 mg/d.
‡The reduced dosage is recommended to minimize the risk of toxic effects because renal function generally declines with age and because side effects have been reported more frequently in elderly people.
§Calculation of estimated creatinine clearance:

Male:  CrCl mL/min =     (140 - age) × weight (kg)
    ------------------------------
    serum creatinine level (µmolL) × 0.81

Female: CrCl mL/min = 0.85 × CrCl (male)

NA = not applicable.

Adapted from Can Commun Dis Rep 1997;23(ACS-2):9 with permission of the Minister of Public Works and Government Services Canada.

[Return to text]


| CMAJ December 1, 1997 (vol 157, no 11) / JAMC le 1er décembre 1997 (vol 157, no 11) |

CMA Webspinners / Les fileurs du Web de l'AMC